Kerry Cooper

Company: Vera Therapeutics

Job title: Senior Vice President Medical Affairs

Seminars:

Review of Recent Data Evaluating the Impact of Atacicept on Long-Term Disease Modification in IgAN 11:00 am

Investigating the role of cytokines BAFF and APRIL and B cells in the pathogenesis of IgAN Reviewing the goals of disease modification in IgAN with regards to Gd-IgA1, hematuria, proteinuria, and eGFR stabilization Examining the results of the ORIGIN2b 96-week open label extension studyRead more

day: Conference Day Two